Xu-Hua Guan

1 ta ish

Hubei Provincial Center for Disease Control and Prevention

1. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

   Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.561376